Clinical trial
ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided…
NCT02928640 · Precision Biopsy, Inc., Industry · Unknown status
Key facts
| NCT number | NCT02928640 |
|---|---|
| Title | ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy |
| Official title | Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing TRUS-Guided Prostrate Biopsy With or Without MR Fusion For Prostrate Tissue Classification Algorithm Development |
| Lead sponsor | Precision Biopsy, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Cellular Diagnosis, Prostate Cancer |
| Intervention type | Device |
| Interventions | ClariCore System |
| Enrollment | 200 |
| Start date | Sep 1, 2016 |
| Primary completion | Jan 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | Oct 10, 2016 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: